Elsevier

Neuropeptides

Volume 22, Issue 3, July 1992, Pages 175-183
Neuropeptides

Neurotensin increases extracellular striatal dopamine levels in vivo

https://doi.org/10.1016/0143-4179(92)90160-XGet rights and content

Abstract

This study employed intracranial microdialysis to assess the effects of neurotensin (NT) infusion on extracellular dopamine (DA) and DA metabolite concentrations in the rat striatum and nucleus accumbens, and the effects of NT on alterations in extracellular DA levels induced by cocaine and the DA D-2 receptor agonist, quinpirole. Direct NT infusion (.10, 1.0, 10.0 μM) did not significantly affect extracellular DA in the nucleus accumbens, but did produce a significant increase in the DA metabolite homovanillic acid (HVA). In contrast, direct NT infusion produced an increase in striatal DA levels, without altering DA metabolites. Neurotensin infusion (.10 μM) into the striatum significantly attenuated the peak DA increase induced by an intraperitoneal (IP) injection of a low dose (10.0 mg/kg) but not a high dose (30.0 mg/kg) of cocaine. Neurotensin infusion (.10 μM) did not affect the decrease in DA and its metabolites induced by an IP injection of a low dose of quinpirole (.03 mg/kg), but did alter the decrease in HVA induced by a high dose of quinpirole (.10 mg/kg). These results suggest that NT differentially affects in vivo DA release in the striatum and nucleus accumbens, and further strengthens the assertion that NT is an important modulator of dopaminergic function.

References (53)

  • C.M. Waters et al.

    Localization of neurotensin receptors in the forebrain of the common marmoset and the effects of treatment with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

    Brain Research

    (1987)
  • M. Ruggeri et al.

    Effects of cholecystokinin peptides and neurotensin on dopamine release and metabolism in the rostral and caudal part of the nucleus accumbens using intracerebral dialysis in the anaesthetized rat

    Neurochemistry International

    (1987)
  • S. Tanganelli et al.

    Neurotensin counteracts apomorphine-induced inhibition of dopamine release as studied by microdialysis in rat neostriatum

    Brain Research

    (1989)
  • P.G. Osborne et al.

    An in vivo microdialysis characterization of extracellular dopamine and GABA in dorsolateral striatum of awake freely moving and halothane anaesthetised rats

    Journal of Neuroscience Methods

    (1990)
  • D.E. Walters et al.

    The D1 agonist SKF-38393 increases dopamine release in the developing rat striatum

    European Journal of Pharmacology

    (1990)
  • T. Zetterstrom et al.

    Effects of apomorphine on the in vivo release of dopamine and its metabolites, studied by brain dialysis

    European Journal of Pharmacology

    (1984)
  • A. Imperato et al.

    The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats

    European Journal of Pharmacology

    (1987)
  • R.E. See et al.

    In vivo assessment of dopamine release and metabolism in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists

    Neuropharmacology

    (1991)
  • G. von Euler et al.

    Neurotensin reduces the affinity of dopamine D2 receptors in membranes from post mortem human caudateputamen

    Neuroscience Letters

    (1990)
  • W.-X. Shi et al.

    Neurotensin modulates autoreceptor mediated dopamine effects on midbrain dopamine cell activity

    Brain Research

    (1991)
  • W.-X. Shi et al.

    Neurotensin attenuates dopamine D2 agonist quinpirole-induced inhibition of midbrain dopamine neurons

    Neuropharmacology

    (1990)
  • W.H. Church et al.

    Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine and benztropine

    European Journal of Pharmacology

    (1987)
  • T.E. Robinson et al.

    Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats

    Brain Research

    (1988)
  • R. Markstein et al.

    Effect of neurotensin and its fragments neurotensin-(1–6) and neurotensin-(8–13) on dopamine release from cat striatum

    European Journal of Pharmacology

    (1988)
  • M.E. deQuidt et al.

    Neurotensin facilitates dopamine release in vitro from rat striatal slices

    Brain Research

    (1983)
  • J.A. Gilbert et al.

    Neurotensin stimulates formation of cyclic GMP in murine neuroblastoma clone NIE-115

    European Journal of Pharmacology

    (1984)
  • Cited by (31)

    • Endocannabinoid Signaling in the Striatum

      2010, Handbook of Behavioral Neuroscience
      Citation Excerpt :

      This effect also requires activation of group I mGluRs and D2 dopamine receptors, and the role of the NT receptor is most likely stimulation of postsynaptic eCB production. This may be a direct effect or secondary to increased dopamine or glutamate release (Okuma et al., 1983; Chapman et al., 1992; Diaz-Cabiale et al., 2002; Matsuyama et al., 2003). Activation of group I mGluRs also produces eCB-mediated short-term depression in striatal brain regions.

    • Intra-accumbens shell injections of SR48692 enhanced cocaine self-administration intake in rats exposed to an environmentally-elicited reinstatement paradigm

      2009, Brain Research
      Citation Excerpt :

      In fact, it has been suggested that NT receptors are mainly targeted to presynaptic sites where they can play a role in the regulated secretion and/or retrograde signaling (Pickel et al., 2001). Interestingly, this presynaptic localization of NT1 receptors is associated with increased DA release after local NT injection (Chapman et al., 1992). We, therefore, propose that the increase in cocaine self-administration, observed after blockade of NT receptors, might be due to a disruption in the interactions of presynaptic NT1 and D2 receptors.

    • Neurotensin reduces glutamatergic transmission in the dorsolateral striatum via retrograde endocannabinoid signaling

      2008, Neuropharmacology
      Citation Excerpt :

      Still, this hypothesis cannot be ruled out at present. Finally, since NTS1 and D2 receptors are colocalized within single axon terminals, NT may simply potentiate dopamine release by antagonizing the function of presynaptic D2 autoreceptors, as has previously been suggested (Chapman et al., 1992; Diaz-Cabiale et al., 2002; Delle Donne et al., 2004). Indeed, it is well documented that NT stimulates dopamine release in striatal slices (Okuma et al., 1983; Battaini et al., 1986; Hetier et al., 1988).

    • Brain levels of neuropeptides in human chronic methamphetamine users

      2007, Neuropharmacology
      Citation Excerpt :

      These neuropeptides have also been shown to alter activity of DA pathways known or suspected to influence motor functions, emotions, and addictive behavior (DYN (Reid et al., 1988; Steiner and Gerfen, 1998); MENK (Steiner and Gerfen, 1998); NPY (Midgley et al., 1994); NT (Wagstaff et al., 1996b); SP (Reid et al., 1988)). Specifically, application of NT (Chapman et al., 1992) or SP (Tang et al., 1998) are reported to be excitatory, while DYN and MENK are reported to be inhibitory on striatal dopaminergic activity (Steiner and Gerfen, 1998). Consequently, there are actions both by drugs of abuse and these neuropeptide systems on DA pathways (Ervin et al., 1981; Steiner and Gerfen, 1998).

    View all citing articles on Scopus
    View full text